Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bedaquiline, pretomanid and linezolid in multidrug-resistant and pre-extensively drug-resistant tuberculosis in refugees from Ukraine and Somalia in Germany

18 Apr 2024

Abstract excerpt

According to the WHO 2023 tuberculosis report, in the European Union region there are approximately 200.000 tuberculosis cases per year, among which 30.000 are rifampicin-resistant with treatment success rates of 57% [1], indicating a considerable gap from the UN's goal of an 80% reduction by 2030. Footnotes This manuscript has recently been accepted for publication in the European Respiratory Journal . It is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Infectious Diseases and Tuberculosis
Share to Pneumocystis jirovecii pneumonia detection and treatment
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38636988
DOI: 10.1183/13993003.00303-2024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bedaquiline, pretomanid and linezolid in multidrug-resistant and pre-extensively drug-resistant tuberculosis in refugees from Ukraine and Somalia in GermanyPMID 38636988Read ↗

TB Anywhere, TB Everywhere. The First Case of pre-Extensively Drug Resistant Tuberculosis Treated with BPaL in Italy: Challenges and Opportunities for Transborder Collaboration.Semantic proximity Read ↗

Drug-Resistant Tuberculosis 2020: Where We StandSemantic proximity Read ↗

Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.Semantic proximity Read ↗

First detection of a Mycobacterium tuberculosis XDR clinical isolate harbouring an RpoB I491F mutation in a Ukrainian patient treated in Germany, October 2023.Semantic proximity Read ↗

[Emerging and drug-resistant infectious diseases--multi-drug resistant tuberculosis].Semantic proximity Read ↗

Changes in the epidemiological situation of multidrug-resistant tuberculosis in Poland in the years 2018-2022.Semantic proximity Read ↗

HIV-negative Rifampicin Resistance/Multidrug-Resistant Extrapulmonary Tuberculosis in China from 2015 to 2019: A clinical retrospective investigation study from a National Tuberculosis Clinical Research CenterSemantic proximity Read ↗

Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanidSemantic proximity Read ↗

The past, present and future of tuberculosis treatment.Semantic proximity Read ↗

Assessment of Pharmacotherapy and Clinical Outcomes of Treatment for the Development of Cardiovascular Disease among Tuberculosis PatientsSemantic proximity Read ↗

Protocol for a phase 2, partially-blinded, randomised trial assessing the safety and efficacy of sorfequiline or bedaquiline, in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)Semantic proximity Read ↗

Detection and Frequency of Mycobacterium tuberculosis and Rifampicin Resistance Among Patients Attending the National TB Control Program in Sana'a, Yemen Using Xpert- MTB/RIF AssaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.